Verge Genomics

Verge Genomics is a clinical-stage biotechnology company that uses artificial intelligence and human genomic data to accelerate drug discovery and development for complex neurodegenerative diseases such as ALS and Parkinson's. Its proprietary CONVERGE® platform integrates large-scale multi-omic patient datasets with machine learning to identify novel therapeutic targets with a higher probability of clinical success. The company serves patients and pharmaceutical partners by developing drug candidates more efficiently, bypassing traditional animal models in favor of an all-in-human approach.